These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1850 related articles for article (PubMed ID: 12739251)
1. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
2. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance. Ward PL; Koeppen HK; Hurteau T; Rowley DA; Schreiber H Cancer Res; 1990 Jul; 50(13):3851-8. PubMed ID: 2112981 [TBL] [Abstract][Full Text] [Related]
3. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen. Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053 [TBL] [Abstract][Full Text] [Related]
4. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes. Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437 [TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts). Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976 [TBL] [Abstract][Full Text] [Related]
6. The immunogenic potential of human fetal retinal pigment epithelium and its relation to transplantation. Rezai KA; Semnani RT; Patel SC; Ernest JT; van Seventer GA Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2662-71. PubMed ID: 9375586 [TBL] [Abstract][Full Text] [Related]
7. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft. Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758 [TBL] [Abstract][Full Text] [Related]
8. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network. Bodey B; Bodey B; Kaiser HE In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303 [TBL] [Abstract][Full Text] [Related]
9. MHC class I antigens, immune surveillance, and tumor immune escape. Garcia-Lora A; Algarra I; Garrido F J Cell Physiol; 2003 Jun; 195(3):346-55. PubMed ID: 12704644 [TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes. Buckner FS; Wipke BT; Van Voorhis WC Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608 [TBL] [Abstract][Full Text] [Related]
11. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation. Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388 [TBL] [Abstract][Full Text] [Related]
12. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors. Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647 [TBL] [Abstract][Full Text] [Related]
13. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly. Sibille C; Gould K; Hämmerling G; Townsend A Eur J Immunol; 1992 Feb; 22(2):433-40. PubMed ID: 1537379 [TBL] [Abstract][Full Text] [Related]
14. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction. Kingston AE; Bergsteinsdottir K; Jessen KR; Van der Meide PH; Colston MJ; Mirsky R Eur J Immunol; 1989 Jan; 19(1):177-83. PubMed ID: 2493382 [TBL] [Abstract][Full Text] [Related]
15. Genetically engineered grafts to study xenoimmunity: a role for indirect antigen presentation in the destruction of major histocompatibility complex antigen deficient xenografts. Markmann JF; Campos L; Bhandoola A; Kim JI; Desai NM; Bassiri H; Claytor BR; Barker CF Surgery; 1994 Aug; 116(2):242-8; discussion 248-9. PubMed ID: 8047991 [TBL] [Abstract][Full Text] [Related]
17. Rejection of K1735 murine melanoma in syngeneic hosts requires expression of MHC class I antigens and either class II antigens or IL-2. Chen PW; Ananthaswamy HN J Immunol; 1993 Jul; 151(1):244-55. PubMed ID: 8326126 [TBL] [Abstract][Full Text] [Related]
18. Direct identification of human tumor-associated peptide antigens and a preclinical model to evaluate their use. Engelhard VH; Bullock TN; Colella TA; Mullins DW Cancer J; 2000 May; 6 Suppl 3():S272-80. PubMed ID: 10874498 [TBL] [Abstract][Full Text] [Related]
19. Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice. Svane IM; Engel AM; Nielsen MB; Ljunggren HG; Rygaard J; Werdelin O Eur J Immunol; 1996 Aug; 26(8):1844-50. PubMed ID: 8765030 [TBL] [Abstract][Full Text] [Related]
20. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status. Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]